Full-Time

Account Executive Business Development

Posted on 1/7/2026

Deadline 1/7/27
Versiti

Versiti

1,001-5,000 employees

Blood centers providing donations and research

No salary listed

Milwaukee, WI, USA

In Person

Travel up to 50-60% of time; must have valid driver’s license and access to a vehicle.

Category
Business & Strategy (1)
Requirements
  • Bachelor's Degree Life Science, Business, Sales, Marketing or related field required
  • 1-3 years relevant field-based sales experience required
  • 1-3 years Key account management experience: Demonstrated expertise in managing complex accounts through a key account management approach. Responsible for mapping out stakeholders and their decision making process, and coordinating efforts across the organization. required
  • Equivalent combination of education and related experience may be substituted with the approval of Human Resources and Diagnostic Laboratories Senior Management. required
  • Understanding of health care market, hospital services, and diagnostic lab products and services. required
  • Highly goal-oriented: self-starter with the ability to work independently with minimal direct supervision required
  • Enthusiasm, positive attitude, authenticity and perseverance necessary for success in a direct sales career including prospecting, making “cold” calls, selling high-end products/services, and discerning and overcoming objections required
  • Strong organizational, communication, and problem solving skills required
  • Excellent verbal and written communication skills including presentation and negotiation skills required
  • Outstanding interpersonal and customer service skills including the ability to establish credibility and develop professional working relationships with all levels of staff within the scientific community required
  • Proficient computer skills to work with personal computers and laboratory information systems required
  • Valid U.S. Driver’s License, access to a vehicle, ability to travel as defined by business needs. Travel up to 50-60% of time is likely. required
Responsibilities
  • BUSINESS DEVELOPMENT & SALES - Manage renewals, expansions, and service-level upsell within their domain.
  • Secure new business within the clinical trial services market.
  • Drive new business across the responsible domain.
  • Call on and position Diagnostic Laboratory services to prospective and current partners (including physicians, hospital administrators, and laboratory management/staff) to meet revenue goals.
  • Maintain and grow knowledge of products and service lines of the Diagnostic Laboratory.
  • Present at trade shows and client meetings as a representative of Versiti and with relevant professional organizations to promote the Diagnostic Laboratory business.
  • CLIENT & ACCOUNT MANAGEMENT - Serve as primary client contact for sponsors within the appropriate domain.
  • Develop and maintain collaborative working relationships with designated Key Accounts.
  • Serve as primary contact point, manage contract negotiation, manage account growth, conduct annual business reviews, and resolve client concerns.
  • Manage one or more national accounts: develop needs assessments, conduct stakeholder mapping, prepare/manage pipeline, and build relationships within assigned territories.
  • Serve as Voice of Customer on client needs, issues/concerns, satisfaction, expansion opportunities, competitor activities/strategies, and marketing/advertising campaigns.
  • Support the organization of client visits and bid defenses.
  • PLANNING & REPORTING - Achieve quarterly and annual sales plan for assigned domain.
  • Actively manage CRM: enter call activity, qualify leads, update opportunities, manage pipeline, and ensure accuracy of account-specific information.
  • Use CRM tools to manage and document territory and client information.
  • Plan work schedule efficiently to maximize client visits/calls and minimize expense.
  • Maintain a 90-day travel schedule to achieve a minimum of 40% time in the field with external prospects and partners.
  • MARKETING INTELLIGENCE & EXPERTISE - Maintain current professional knowledge in the clinical trial landscape, Versiti’s and its affiliates’ expertise within Central Lab Services, Hematology, Transfusion Medicine, Transplant/Oncology, and other service offerings to provide “value-added” expanded Company services.
  • COLLABORATION & OPERATIONS - Support Enterprise Sales Directors with SME input during larger pursuits.
  • Collaborate with operational groups to complete proposals and finalize contracts.
  • Collaborate with company resources to achieve superior customer satisfaction.
  • Interact well with operations and maintain a general understanding of company capabilities, capacity, and timelines.
  • Performs other duties as required or assigned which are reasonably within the scope of the duties in this job classification
  • Understands and performs in accordance with all applicable regulatory and compliance requirements
  • Complies with all standard operating policies and procedures
Desired Qualifications
  • Master’s Degree desired
  • Technical background to include experience in laboratory or medical operations in lieu of required degree preferred
  • Relevant industry certifications desired

Versiti coordinates a network of linked blood centers and a research organization focused on blood health. It collects, tests, processes, stores, and distributes blood, organs, tissue, and bone marrow to hospitals to meet urgent patient needs. Its blood products and transfusion services are supported by research from the Blood Research Institute, which works on cellular therapies, oncology, and genomics to advance personalized medicine. The company differentiates itself by operating as a partnership of centers with a strong emphasis on scientific rigor, donor relationships, and broad collaboration with hospitals, aiming to be the go-to partner for blood health services. Its goal is to save lives by providing safe, available blood products while driving research to improve treatments and outcomes.

Company Size

1,001-5,000

Company Stage

Grant

Total Funding

$25.5M

Headquarters

Milwaukee, Wisconsin

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • MACC Fund's $11.5M funds pediatric leukemia research, expanding institute late 2026.
  • 4D Path partnership accelerates AI-driven oncology biomarkers since April 2026.
  • National referrals for specialty blood products boost high-margin revenues.

What critics are saying

  • $80M institute expansion overruns strain reserves by mid-2027.
  • 4D Path QPOR fails FDA validation, losing oncology contracts in 2027.
  • Red Cross poaches donors, cutting 230K units 20% by 2028.

What makes Versiti unique

  • Versiti integrates blood donation, diagnostic labs, and research since 1947.
  • VBRI pioneers gene therapy for leukemia and hemophilia with global partners.
  • Unique genotyping enables rare blood matching unavailable elsewhere worldwide.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Company Match

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
4D Path
Apr 21st, 2026
Versiti Clinical Trials Services partners with 4D Path to accelerate personalized cancer treatment development.

Versiti Clinical Trials Services partners with 4D Path to accelerate personalized cancer treatment development. April 21, 2026. The AI-driven platform delivers tumor treatment predictive biomarkers to oncology researchers faster, more accurately, and at scale. MILWAUKEE and NEWTON, MA - April 21, 2026 - Versiti Clinical Trials Services (VCTS) has launched a partnership with 4D Path to bring cutting-edge treatment predictive biomarker technology to researchers developing lifesaving, personalized cancer treatments. The collaboration makes 4D Path's Q-Plasia OncoReader (QPOR(TM) platform available to pharmaceutical companies and clinical research organizations working with VCTS, giving them powerful new tools to understand how individual cancers respond to treatment. QPOR(TM) transforms routine biopsy images into clear treatment predictive biomarkers that reveal how tumors and immune systems interact. The physics-inspired, AI-driven deterministic platform delivers these insights faster and at lower cost than traditional methods, helping researchers make critical decisions earlier in the development process. The QPOR(TM) platform is available to VCTS clients immediately. "Every day matters when we're developing treatments that could save lives," Chris Miskel, President and CEO of Versiti, says. "This partnership gives our clients the speed and precision they need to bring personalized cancer therapies to patients who can no longer wait. We're seeing a deeper understanding of how individual cancers behave, with unprecedented clarity that wasn't possible before." The QPOR(TM) platform works across cancers, providing robust, consistent, and reproducible results that meet regulatory standards. Clinical trial sponsors gain biologically explainable, treatment predictive insights that speed decision-making while reducing costs. For patients, this means potentially faster access to treatments tailored to their specific cancer. "VCTS shares our commitment to making precision medicine accessible and practical," said Tathagata Dasgupta, founder, president, and CTO of 4D Path. "Together, we're giving researchers the clarity and insights they need to develop better treatments faster, without special processing or added complexity." The partnership strengthens VCTS's position as a leader in oncology clinical trials, offering clients a comprehensive platform that combines proven trial management expertise with breakthrough analytical capabilities. About Versiti Clinical Trials Services Versiti Clinical Trials Services, a division of Versiti Blood Health, Inc., is dedicated to advancing life sciences research and improving patient outcomes through innovative clinical study support services. 4D Path Inc. collaborate with healthcare professionals, research institutions, and industry partners to develop life-changing solutions. Its commitment to scientific excellence, patient-centered care, and ethical research practices drives 4D Path Inc. to explore groundbreaking solutions for a healthier future. About 4D Path 4D Path has created a groundbreaking platform, the patented Q-Plasia OncoReader (QPOR(TM), designed to directly measure and quantify cell cycle deregulation and tumor immune microenvironment dynamics to predict a patient's response to therapy. This unprecedented view into tumor dynamics creates new pathways from clinical use to research and development applications - bringing more effective, personalized therapies to patients. 4D Path is focused on a bold vision where every person impacted by cancer is diagnosed quickly and accurately and receives the best, most personalized treatment plan to beat cancer and live a longer, healthier life. For additional information, please visit www.4dpath.com or follow 4D Path on LinkedIn. (617) 558-0010 Versiti PR Contact Kristin Paltzer Senior Manager Media and Public Relations [email protected] (414) 937-6143

Aspire North Realtors
Mar 20th, 2026
Aspire North community blood drive.

Aspire North community blood drive. 03.20.2026 By Heather Sauer On Friday, March 20th, Aspire North Realtors proudly hosted a community blood drive from 11:00 AM - 3:30 PM, bringing members and community supporters together for an important cause, helping save lives through blood donation. Its goal for the day was to collect 15 units of whole blood, and thanks to the generosity of its community, Aspire North REALTORS were able come extremely close to that with 14 units of whole blood collected. Every donation has the potential to help multiple patients, making a meaningful impact for individuals and families in need. This blood drive would not have been possible without the support of Versiti, who partnered with Aspire North Realtors to organize and facilitate the event. Their team ensured the process was smooth, safe, and welcoming for all donors. Aspire North REALTORS would also like to extend a heartfelt thank you to everyone who volunteered their time to donate. Your willingness to give back demonstrates the strong sense of community that makes Aspire North Realtors such a special organization. Whether you were a first-time donor or a returning one, your contribution truly matters. Events like this remind Aspire North REALTORS that small acts of generosity can have a powerful impact. Aspire North Realtors is proud to support initiatives that strengthen its community and help those in need. Aspire North REALTORS look forward to continuing opportunities like this in the future and hope even more members will join Aspire North REALTORS next time to help make an even greater difference. Heather Sauer Heather Sauer is the Human Resource Manager for Aspire North Realtors, bringing a strong background in human resources, leadership, and business strategy. She began her career in retail management while earning her Bachelor's degree in Business Administration from Northwood University, later transitioning into human resources at Target, where she served as an Executive Team Leader of Human Resources. During this time, she earned her MBA from the Northwood University DeVos Graduate School. After relocating to Traverse City, Michigan, Heather continued her HR career with a Professional Employer Organization (PEO), managing more than 30 client accounts and partnering closely with leadership teams on employee relations, compliance, and organizational development. In the fall of 2023, she expanded her professional experience into business development and entrepreneurship. In addition to her role at Aspire North Realtors, Heather is also an independent travel agent, helping individuals, families, and groups plan seamless, memorable travel experiences. Her passion for service, organization, and relationship-building carries through both her HR and travel work.

Lake Oswego Review
Mar 3rd, 2026
MACC Fund Commits $11.5 Million to Propel Pediatric Cancer Research at Versiti Blood Research Institute

MACC Fund commits $11.5 million to propel pediatric cancer research at Versiti Blood Research Institute. PR Newswire Today at 8:03am PST PR Newswire MILWAUKEE, March 3, 2026 MILWAUKEE, March 3, 2026 /PRNewswire/ - The MACC Fund has committed $11.5 million to advance pediatric cancer research at the Versiti Blood Research Institute, strengthening a long-standing partnership dedicated to improving outcomes for children facing leukemia and other blood disorders. "The MACC Fund is proud to partner with the Versiti Blood Research Institute to spotlight and accelerate Versiti's pioneering work in leukemia biology, immune discovery, and translational research. Kids deserve better treatment options. Kids deserve to be kids. By expanding our support, we're empowering researchers to move discoveries from the lab to life-changing treatments, faster, smarter, and with renewed hope for every child to thrive," said Becky Pinter, president and CEO of the MACC Fund. The multiyear investment will accelerate high-impact research already underway in pediatric leukemia biology, immune system discovery and translational science that moves insights from the lab toward the bedside. The commitment will support investigator recruitment and retention, expand translational research capacity, advance active clinical and laboratory studies, and provide sustained funding to pursue emerging scientific opportunities in pediatric leukemia. There are two primary types of pediatric leukemia: acute lymphoblastic leukemia, or ALL, and the rarer acute myeloid leukemia, or AML. ALL is the most common cancer among children, with more than 3,000 new cases diagnosed annually in the United States. While survival rates for ALL are approximately 90 percent, AML remains devastating, with nearly half of diagnosed children dying from the disease. Versiti researchers are working to change that trajectory. Current areas of study include: * Developing next-generation precision oncology immunotherapies * Using CAR T-cell therapy to train patients' immune systems to fight cancer * Building a basic understanding and clinical use of natural killer cells * Reducing toxicity in existing treatments * Applying artificial intelligence to bioinformatics to create more targeted, precise therapies Versiti currently has four faculty-level investigators leading pediatric leukemia research projects, with plans to add one to two more in the next 12 months. The institute is conducting two active clinical and translational studies and six active scientific studies, supported by 20 research staff members. In the past two years alone, investigators have published 54 peer-reviewed publications. The multiyear investment will accelerate high-impact research already underway in pediatric leukemia biology, immune system discovery and translational science that moves insights from the lab toward the bedside. The commitment will support investigator recruitment and retention, expand translational research capacity, advance active clinical and laboratory studies, and provide sustained funding to pursue emerging scientific opportunities in pediatric leukemia. This expanded capacity aligns with the 79,000-square-foot Versiti Blood Research Institute expansion, providing the space and infrastructure to scale collaboration, equipment, and pilot projects that will translate discoveries into next-generation therapies for children. The expansion is on track to be completed and open to researchers in late 2026. "When a community chooses to invest in research, it invests in a child's future. The MACC Fund's bold $11.5 million commitment will fuel leading-edge scientific work at Versiti that has the potential to change outcomes for children facing cancer. We are grateful for this partnership and committed to delivering breakthrough discoveries for families in need," said Chris Miskel, president and CEO of Versiti. The MACC Fund has long mobilized community support to fuel childhood cancer research. This investment reflects a shared commitment to strengthening scientific capacity, supporting leading investigators, and sustaining discovery that improves survival rates while reducing treatment toxicity for children. This partnership underscores Milwaukee's leadership in pediatric cancer research while contributing to discoveries that have the potential to impact children nationwide. About the MACC Fund The MACC Fund (Midwest Athletes Against Childhood Cancer, Inc.) is a non-profit founded in 1976 with a mission to fund a cure for childhood cancer and related blood disorders by providing funding for research. Over the years, the MACC Fund has contributed nearly $90 million toward groundbreaking research in these areas. In addition to funding research, the MACC Fund raises awareness and engages the community to bring hope to children and families. About Versiti Versiti, a national leader in blood health innovation, was formed with the mission to improve the health of patients and enable the success of healthcare partners nationally. The organization is a 501(c)(3) not-for-profit headquartered in Milwaukee, with more than 2,700 employees at locations in Illinois, Indiana, Michigan, Ohio, Texas and Wisconsin. Versiti provides innovative, value-added solutions in transfusion medicine, transplantation, and blood-related diseases to meet the needs of its customers. The collective efforts result in improved patient outcomes, expanded access to care, and cost efficiencies for healthcare systems nationwide. For more information, visit Versiti.org. SOURCE Versiti, Inc. This is a paid placement. For further inquiries, please contact PR Newswire directly.

Hearst Television
Feb 10th, 2026
Versiti's lifesaving impact through blood donations and vital research

Versiti's lifesaving impact through blood donations and vital research. Versiti, a nonprofit blood center headquartered in Wisconsin, is saving lives through blood donations and advanced research. Updated: 7:02 PM CST Feb 9, 2026 MILWAUKEE - Versiti, a nonprofit blood center headquartered in Milwaukee, is saving lives through blood donations and advanced research, which is why the organization has been chosen for WISN's monthly "Day of Giving" campaign. "Versiti has been here 79 years as a nonprofit, community-based blood center," said Chris Miskel, president and CEO of Versiti. "We are experts in all things blood, whether that's collecting, processing and distributing to 400 hospitals across the Midwest, or whether that's really advanced blood research to hopefully eradicate blood disease one day." Versiti collects 230,000 units of blood annually from Wisconsin donors, aiding patients at 56 hospitals statewide. While several blood donation organizations exist nationwide, Versiti distinguishes itself as a leader in blood specialty products and research. "We offer testing in specialty areas, so transfusion medicine, hematology and transplantation, not only here in our local community but internationally," said Dr. Matthew Anderson, chief medical officer of Versiti. "Some of the testing that we provide, you actually can't get that testing anywhere else in the world." Most of Versiti's donations remain local, but its advanced testing attracts calls from across the country. "We'll get calls from physicians or hospitals around the country where they're looking for very rare or unique blood types because they have a patient with unique need. We're the first place they call, and we're able to help those patients, even outside our own community," Anderson explained. Recently, a patient in Los Angeles needed a type of blood with only 1% availability in the United States. Versiti sent 10 units to save that person's life. "It's very fine matching that maybe others can't do, but because we've invested in genotyping of our donor base, we're able to find those units and do those precise matches," Miskel said. Versiti is currently working on an expansion of its research institute in Wauwatosa, which is expected to cost $80 million and create 100 jobs in the area. WISN 12 is hosting a blood drive and organizing a phone bank on Wednesday, Feb. 11, 2026, to support the Versiti Blood Center of Wisconsin and its local site, Versiti on King, a new blood donation and community resource center. Those looking to make blood donations are encouraged to schedule an appointment in advance.

Wright State University Athletics
Jan 16th, 2026
Raiders partner for annual blood drive for Bob Grote

Raiders partner for annual blood drive for Bob Grote. Wright State Athletics has again partnered with Versiti Blood Center to host a blood drive on Saturday, January 17, from 9 a.m. to 1 p.m. at the Nutter Center. This event is in honor of former Raider basketball/baseball great and radio commentator Bob Grote, who himself faced a life-threatening health emergency, necessitating 31 units of blood for his treatment. Those unable to attend on January 17 will have an opportunity to contribute to the drive by signing up to donate at the Versiti Blood Center, which is located at 349 S. Main Street in Dayton, from January 19-30. To register, click the registration link featured below. As a gesture of appreciation, all registered donors will receive two tickets to the February 22 Wright State men's basketball game as well as a Donor Love crewneck shirt, available while supplies last. This initiative not only emphasizes the critical role of blood donation but also serves as a tribute to a distinguished member of its Raider family. Your participation will make a meaningful impact on the lives of individuals facing health challenges. Thank you for your support, and Wright State University Raiders look forward to a successful and impactful blood drive.

INACTIVE